Allogene Therapeutics Stock (NASDAQ: ALLO)

Allogene Therapeutics

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

movers image

News

Intraday Update

Markets

Movers

Trading Ideas

ALLO

HEES

INTC

MRNA

OSCR

RXRX

SMCI

ZLAB

Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday

Gene therapy

Biotech

Health Care

General

CABA

KYTX

CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech&#39;s remarkable remission. This breakthrough offers new hope for autoimmune disease patients but faces challenges in cost and manufacturing.

Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges

AGRI

AKAN

AONC

APLD

ATEN

AULT

BDRX

BRSH

CRKN

CSLR

CTNT

DARE

EDBL

FFIE

FWRD

GSX Techedu Inc. American Depositary Shares

GOTU

GWAV

HSAI

ISUN

KEYS

LICN

Larimar Therapeutics, Inc. - Common Stock

LRMR

LUXH

MGOL

MGRX

MMAT

Eaton Vance Massachusetts Municipal Income Trust

NDSN

ONFO

PANW

PEGY

PTON

SCPX

TRNS

WALD

XPEV

XYLO

ZENV

Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics Inc

ALLON THERAPEUTICS INC by Allon Therapeutics Inc.

AlloVir Inc

Allot Ltd

Press Releases

Allogene Therapeutics Acknowledges the Passing of Founding Board Member David Bonderman

Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Small Cap

Opinion

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment

Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases

Management

Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief Technical Officer

Allogene Therapeutics Announces Participation in February Investor Conferences

Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology

Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia

Allogene Therapeutics Announces Participation in March Investor Conference

Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update

CNTX

ERAS

ONCY

TSX:ONC

Absci

Akebia Therapeutics

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Altimmune

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Aura Biosciences

Celcuity

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Chimerix

Erasca

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Heron Therapeutics

Humacyte

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Oruka Therapeutics

PureTech Health plc - American Depositary Shares

PureTech Health

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

Sage Therapeutics

Solid Biosciences

Stoke Therapeutics

Savara

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Upstream Bio

Piper Sandler

HC Wainwright & Co.

Citigroup

Truist Securities

Oppenheimer

Comments

Allogene Therapeutics

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga